2,6-dichloroindophenol has been researched along with Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azimian, SM; Bair, WB; Cabello, CM; Davis, AL; Lamore, SD; Wondrak, GT | 1 |
1 other study(ies) available for 2,6-dichloroindophenol and Breast Cancer
Article | Year |
---|---|
DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma.
Topics: 2,6-Dichloroindophenol; Animals; Antineoplastic Agents; Breast Neoplasms; Caspases; Cell Death; Cell Line, Tumor; Cell Proliferation; DNA Damage; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glutathione; Heat-Shock Proteins; Humans; Immunoblotting; Membrane Potential, Mitochondrial; Mice; NAD(P)H Dehydrogenase (Quinone); Oxidative Stress; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; RNA, Small Interfering | 2011 |